Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 108OTHER 92NIH 10OTHER_GOV 3NETWORK 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 71Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 54Prostatic Neoplasms 48Lung Neoplasms 48Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Interventions

fludarabine phosphate 1fludarabine 1Injections 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Hematologic Diseases × Clear all
NCT06795815 2026-05-07

OHGW-ACP

Azienda USL Reggio Emilia - IRCCS

Phase NA Recruiting
75 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma, Neoplasms

NCT05902845 2024-11-21

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Anhui Provincial Hospital

Phase EARLY_PHASE1 Completed
4 enrolled
Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Anhui Provincial Hospital

Phase 1 Unknown
10 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡